| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |